Catalyst Pharm Inc
(CPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,097 | 2,216 | 1,410 | 6,029 | 5,475 |
| Marketable Securities | 30,178 | 21,495 | 14,007 | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 134 |
| TOTAL | $43,828 | $25,320 | $16,727 | $6,228 | $5,775 |
| Non-Current Assets | |||||
| PPE Net | 71 | 41 | 54 | 12 | 46 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 11 |
| TOTAL | $80 | $50 | $63 | $21 | $56 |
| Total Assets | $43,908 | $25,370 | $16,789 | $6,249 | $5,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,814 | 851 | 1,366 | 264 | 106 |
| Accrued Expenses | 4,041 | 1,289 | 281 | 570 | 193 |
| TOTAL | $5,855 | $2,140 | $1,647 | $834 | $299 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,811 | 1,839 | 521 | 1,655 | 15 |
| TOTAL | $2,811 | $1,839 | $521 | $1,655 | $15 |
| Total Liabilities | $8,666 | $3,978 | $2,167 | $2,489 | $314 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,445 | 54,146 | 41,421 | 24,742 | 21,655 |
| Common Shares | 69 | 54 | 41 | 25 | 19 |
| Retained earnings | -69,843 | -54,334 | -42,179 | -38,103 | -31,712 |
| TOTAL | $35,242 | $21,391 | $14,622 | $3,761 | $5,518 |
| Total Liabilities And Equity | $43,908 | $25,370 | $16,789 | $6,249 | $5,832 |